DAFNA Capital Management »

Adlai Nortye Ltd Sponsored shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Adlai Nortye Ltd Sponsored (ANL) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Adlai Nortye Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Adlai Nortye Ltd Sponsored held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adlai Nortye Ltd Sponsored by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8M 240k 11.50

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Compass Pathways Sponsored Ads (CMPS)
Stereotaxis Com New (STXS)
Nektar Therapeutics Com New (NKTR)
Denali Therapeutics (DNLI)
Ideaya Biosciences (IDYA)
AtriCure (ATRC)
Xenon Pharmaceuticals (XENE)
Cytokinetics Com New (CYTK)
Arcus Biosciences Incorporated (RCUS)
Ascendis Pharma A/s Ord Shs (ASND)
Neurocrine Biosciences (NBIX)
Axogen (AXGN)
Insulet Corporation (PODD)

View all positions for DAFNA Capital Management

Top funds holding Adlai Nortye Ltd Sponsored

Cormorant Asset Management
VR Adviser
Balyasny Asset Management
Point72 Asset Management
MPM Oncology Impact Management
Perceptive Advisors
Casdin Capital
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Braidwell
Squadron Capital Management
Eventide Asset Management
Superstring Capital Management
Adage Capital Partners GP

View all funds holding Adlai Nortye Ltd Sponsored